Global Expansion Avalere Health has announced a Japan office expansion in 2026, signaling an active push into Asia. This presents sales opportunities for localized regulatory, market access, and commercial strategy services, as well as partnerships with local biopharma firms seeking global reach.

End-to-End Solutions The company emphasizes a full-spectrum offering spanning Consulting; Medical; Policy, Access, Value, and Evidence; Marketing; and Digital Experience Technology. Leverage these integrated capabilities to position bundled services for clients aiming to streamline lifecycle management and optimize market access.

Genomics & CGP Recent launches include guides and pathways to Precision Cancer Care and Comprehensive Genomic Profiling (CGP), highlighting a strategic focus on genomic-driven patient access. Target biopharma and health systems pursuing CGP integration to accelerate payer coverage and patient access programs.

Policy and Payer Focus Leadership additions in policy and public health, along with high-level industry engagement, indicate a strengthened capability in navigating reimbursement, payer strategies, and regulatory considerations. Market to firms needing policy advocacy and value-based access to optimize product launches.

Global Footprint & Partnerships New office openings and strategic offerings expand Avalere Health’s geographic reach and service depth. Target multinational biopharma companies seeking a partner to harmonize global launches, local market access, and cross-border commercialization strategies.